Mass Spectrometry-Based Serum and Plasma Peptidome Profiling for Prediction of Treatment Outcome in Patients With Solid Malignancies

INTRODUCTION. Treatment selection tools are needed to enhance the efficacy of targeted treatment in patients with solid malignancies. Providing a readout of aberrant signaling pathways and proteolytic events, mass spectrometry-based (MS-based) peptidomics enables identification of predictive biomark...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Labots, Mariette, Schütte, Lisette M., van der Mijn, Johannes C., Pham, Thang V., Jiménez, Connie R., Verheul, Henk M.W.
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2014
Assuntos:
Cancer Diagnostics and Molecular Pathology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4200992/
https://ncbi.nlm.nih.gov/pubmed/25187478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0101
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados